Learning Objective:
By the end of this lesson, learners will be able to select appropriate antihypertensive therapy tailored to patients with common comorbidities, ensuring both efficacy and safety.
Use of Antihypertensive Drugs in Comorbid Conditions
| Indication | Suitable Drug(s) |
|---|---|
| Angina | Beta blockers, Calcium-channel blockers (CCBs) |
| Diabetes | ACE inhibitors (ACEIs), Angiotensin-receptor blockers (ARBs) |
| Heart failure | ACEIs, ARBs, Beta blockers |
| Post-myocardial infarction (Post-MI) | Beta blockers |
| Benign prostatic hyperplasia (BPH) | Alpha blockers |
| Dyslipidemias | Alpha blockers, CCBs, ACEIs/ARBs |
| Chronic kidney disease | ACEIs, ARBs |
Key Points:
- Selection of antihypertensive therapy should account for comorbid conditions to maximize benefit and minimize harm.
- ACEIs and ARBs are preferred in patients with diabetes or chronic kidney disease due to renal protective effects.
- Beta blockers and CCBs are ideal in patients with angina or post-MI for cardiovascular protection.
- Alpha blockers are particularly useful in BPH due to smooth muscle relaxation in the prostate and bladder neck.
- Some drugs (like ACEIs/ARBs and alpha blockers) can positively influence lipid profiles in patients with dyslipidemia.
